Fig. 1From: Combination therapy with erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy: an open-label pilot study to assess the safety and feasibilityHeart rates during and after hypothermia therapy (mean ± SD). The mean heart rate decreased to 110 bpm during the therapy but rose to 134 bpm after rewarming. HR, heart rate; Epo, erythropoietin; Mg: magnesium sulfateBack to article page